- Home
- VKTX vs APLE Comparison
VKTX vs APLE Comparison
Compare VKTX & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- APLE
- Stock Information
- Founded
- VKTX 2012
- APLE 2007
- Country
- VKTX United States
- APLE United States
- Employees
- VKTX N/A
- APLE N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- APLE Real Estate Investment Trusts
- Sector
- VKTX Health Care
- APLE Real Estate
- Exchange
- VKTX Nasdaq
- APLE Nasdaq
- Market Cap
- VKTX 2.8B
- APLE 2.8B
- IPO Year
- VKTX 2015
- APLE 2015
- Fundamental
- Price
- VKTX $28.14
- APLE $12.12
- Analyst Decision
- VKTX Buy
- APLE Buy
- Analyst Count
- VKTX 12
- APLE 4
- Target Price
- VKTX $84.00
- APLE $15.75
- AVG Volume (30 Days)
- VKTX 3.9M
- APLE 3.5M
- Earning Date
- VKTX 07-23-2025
- APLE 08-06-2025
- Dividend Yield
- VKTX N/A
- APLE 7.92%
- EPS Growth
- VKTX N/A
- APLE N/A
- EPS
- VKTX N/A
- APLE 0.79
- Revenue
- VKTX N/A
- APLE $1,429,658,000.00
- Revenue This Year
- VKTX N/A
- APLE $1.43
- Revenue Next Year
- VKTX N/A
- APLE $2.13
- P/E Ratio
- VKTX N/A
- APLE $15.25
- Revenue Growth
- VKTX N/A
- APLE 4.98
- 52 Week Low
- VKTX $18.92
- APLE $10.44
- 52 Week High
- VKTX $81.73
- APLE $16.50
- Technical
- Relative Strength Index (RSI)
- VKTX 55.39
- APLE 60.63
- Support Level
- VKTX $25.80
- APLE $11.54
- Resistance Level
- VKTX $28.80
- APLE $11.95
- Average True Range (ATR)
- VKTX 1.65
- APLE 0.26
- MACD
- VKTX 0.11
- APLE 0.07
- Stochastic Oscillator
- VKTX 86.93
- APLE 95.78
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.